Home/Filings/4/0000950170-24-115031
4//SEC Filing

Ciaramella Giuseppe 4

Accession 0000950170-24-115031

CIK 0001745999other

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 4:44 PM ET

Size

15.9 KB

Accession

0000950170-24-115031

Insider Transaction Report

Form 4
Period: 2024-10-14
Transactions
  • Exercise/Conversion

    Common Stock

    2024-10-14$0.67/sh+27,318$18,303196,934 total
  • Exercise/Conversion

    Common Stock

    2024-10-14$7.22/sh+1,457$10,520211,370 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-10-1427,3180 total
    Exercise: $0.67From: 2024-04-03Exp: 2028-05-08Comon Stock (27,318 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-10-141,4570 total
    Exercise: $7.22Exp: 2029-05-31Comon Stock (1,457 underlying)
  • Exercise/Conversion

    Common Stock

    2024-10-14$4.22/sh+12,979$54,771209,913 total
  • Sale

    Common Stock

    2024-10-14$26.27/sh51,110$1,342,752160,260 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-10-1412,9790 total
    Exercise: $4.22From: 2024-04-03Exp: 2029-02-13Comon Stock (12,979 underlying)
Footnotes (4)
  • [F1]The stock option exercises were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 28, 2024.
  • [F2]The shares of Common Stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 28, 2024.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.00 to $26.56, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F4]This stock option vested as to 25% on the first anniversary of the vesting commencement date, October 1, 2019, and at a rate of 2.78% each month thereafter until the option was fully vested.

Documents

1 file

Issuer

Beam Therapeutics Inc.

CIK 0001745999

Entity typeother

Related Parties

1
  • filerCIK 0001786322

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:44 PM ET
Size
15.9 KB